Sex-Gender Differences in Irritable Bowel Syndrome

被引:158
作者
Kim, Young Sun [1 ]
Kim, Nayoung [2 ,3 ,4 ]
机构
[1] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Inst Healthcare Res, Dept Internal Med, Seoul, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Gender; Hormones; Irritable bowel syndrome; Sex; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; PLACEBO-CONTROLLED TRIAL; GASTROESOPHAGEAL-REFLUX DISEASE; RANDOMIZED CONTROLLED-TRIAL; CHLORIDE CHANNEL ACTIVATOR; GUT-MICROBIOTA; CHRONIC CONSTIPATION; PRIMARY-CARE; DOUBLE-BLIND;
D O I
10.5056/jnm18082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Because of the sex-gender differences that are shown in a diversity of physiological and psychological factors, it can be speculated that the clinical presentation of symptoms as well as treatment strategies in women and men with irritable bowel syndrome (IBS) may differ. Studies have revealed that IBS is more common in women than men. As for the IBS subtype, IBS with constipation is significantly more prevalent among women than men. Sex hormones and gender differences may play important roles in the pathophysiology of IBS. However, its pathophysiologic mechanisms still remain largely unknown, and therapeutic implications are limited. Moreover, women IBS patients have been reported to feel more fatigue, depression, anxiety, and lower quality of life than men IBS patients. Furthermore, there has been evidence of differences in the appropriate treatment efficacy to IBS in men and women, although relatively few men are enrolled in most relevant clinical trials. A more sex-gender-oriented approach in the medical care setting could improve understanding of heterogeneous patients suffering from IBS. An individualized and multicomponent approach including sex and gender issues might help improve the treatment of IBS.
引用
收藏
页码:544 / 558
页数:15
相关论文
共 144 条
  • [1] Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?
    Adeyemo, M. A.
    Spiegel, B. M. R.
    Chang, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (06) : 738 - 755
  • [2] Ahlawat Sushil K, 2006, Gend Med, V3, P31, DOI 10.1016/S1550-8579(06)80192-0
  • [3] Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation
    Ait-Belgnaoui, Afifa
    Payard, Isabelle
    Rolland, Claire
    Harkat, Cherryl
    Braniste, Viorica
    Theodorou, Vassillia
    Tompkins, Thomas A.
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (01) : 138 - 146
  • [4] Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome
    Ali, A
    Toner, BB
    Stuckless, N
    Gallop, R
    Diamant, NE
    Gould, MI
    Vidins, EI
    [J]. PSYCHOSOMATIC MEDICINE, 2000, 62 (01): : 76 - 82
  • [5] Gonadal hormones and sex differences in pain reactivity
    Aloisi, AM
    [J]. CLINICAL JOURNAL OF PAIN, 2003, 19 (03) : 168 - 174
  • [6] Cross-sex hormone administration changes pain in transsexual women and men
    Aloisi, Anna Maria
    Bachiocco, Valeria
    Costantino, Antonletta
    Stefani, Rita
    Ceccarelli, Ilaria
    Bertaccini, Alessandro
    Meriggiola, Maria Cristina
    [J]. PAIN, 2007, 132 : S60 - S67
  • [7] Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics
    Anderson, GD
    [J]. JOURNAL OF WOMENS HEALTH, 2005, 14 (01) : 19 - 29
  • [8] Constructing the 'gender-specific body': A critical discourse analysis of publications in the field of gender-specific medicine
    Annandale, Ellen
    Hammarstrom, Anne
    [J]. HEALTH, 2011, 15 (06): : 571 - 587
  • [9] Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy
    Barshop, Kenneth
    Staller, Kyle
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2017, 8 (11) : 153 - 160
  • [10] Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis
    Bashashati, M.
    Rezaei, N.
    Shafieyoun, A.
    McKernan, D. P.
    Chang, L.
    Oehman, L.
    Quigley, E. M.
    Schmulson, M.
    Sharkey, K. A.
    Simren, M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (07) : 1036 - 1048